Literature DB >> 27215245

Primary hyperoxaluria in infants.

Manel Jellouli1, Mariem Ferjani1, Kamel Abidi1, Chokri Zarrouk1, Ouns Naija1, J Abdelmoula2, Tahar Gargah1.   

Abstract

The infantile form of primary hyperoxaluria type-1 (PH-1) is characterized by a rapid progression to the end-stage renal disease (ESRD) due to both increased oxalate load and reduced glomerular filtration rate. In the literature, data on this form are limited. The purpose of this study is to analyze retrospectively the clinical, biological, and radiological features of children who were diagnosed with PH-1 during the 1(st) year of life. We reviewed the records of all children with PH-1 diagnosed and followed-up at our department between January 1995 and December 2013. Among them, only infants younger than 12 months of age were retrospectively enrolled in the study. Fourteen infants with the median age of two months were enrolled in the study. At diagnosis, 11 patients had ESRD. All patients had nephrocalcinosis and two of them had calculi. The diagnosis was established in nine patients on the basis of the positive family history of PH-1, bilateral nephrocalcinosis, and quantitative crystalluria. In four patients, the diagnosis was made with molecular analysis of DNA. Kidney biopsy contributed to the diagnosis in one patient. During follow-up, two patients were pyridoxine sensitive and preserved renal function. Seven among 11 patients who had ESRD died, four patients are currently undergoing peritoneal dialysis. Children with infantile PH and ESRD are at high risk of early death. Peritoneal dialysis is not a treatment of choice. Combined liver-kidney transplantation is mandatory.

Entities:  

Mesh:

Year:  2016        PMID: 27215245     DOI: 10.4103/1319-2442.182389

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  5 in total

1.  Characteristics of the genotype and phenotype in Chinese primary hyperoxaluria type 1 populations.

Authors:  Fangzhou Zhao; Jun Li; Lei Tang; Chunming Li; Wenying Wang; Chen Ning
Journal:  Urolithiasis       Date:  2020-06-18       Impact factor: 3.436

Review 2.  Primary hyperoxaluria type 1 in developing countries: novel challenges in a new therapeutic era.

Authors:  Neveen A Soliman; Sameh Mabrouk
Journal:  Clin Kidney J       Date:  2022-05-17

3.  Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry.

Authors:  Lisa J Deesker; Sander F Garrelfs; Giorgia Mandrile; Michiel J S Oosterveld; Pierre Cochat; Georges Deschênes; Jérôme Harambat; Sally-Anne Hulton; Asheeta Gupta; Bernd Hoppe; Bodo B Beck; Laure Collard; Rezan Topaloglu; Larisa Prikhodina; Eduardo Salido; Thomas Neuhaus; Jaap W Groothoff; Justine Bacchetta
Journal:  Kidney Int Rep       Date:  2022-04-20

4.  A novel nonsense variant of the AGXT identified in a Chinese family: special variant research in the Chinese reference genome.

Authors:  Chang Bao Xu; Xu Dong Zhou; Hong En Xu; Yong Li Zhao; Xing Hua Zhao; Dan Hua Liu; Yong An Tian; Xin Xin Hu; Jing Yuan Guan; Jian Cheng Guo; Wen Xue Tang; Xia Xue
Journal:  BMC Nephrol       Date:  2021-03-10       Impact factor: 2.388

5.  Clinical analysis of 13 children with primary hyperoxaluria type 1.

Authors:  Jin-Ai Lin; Xin Liao; Wenlin Wu; Lixia Xiao; Longshan Liu; Jiang Qiu
Journal:  Urolithiasis       Date:  2021-03-15       Impact factor: 3.436

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.